Source: DGNews  |  Posted 9 years ago

WEST CHESTER, PA -- August 30, 2002 -- Cephalon, Inc., an international biopharmaceutical company, announced today that regulatory authorities have granted marketing approval for modafinil in Australia, New Zealand and the Republic of Korea. Cephalon licensees, CSL Limited in Australia and New Zealand and Choongwae Pharma Corporation in the Republic of Korea will market modafinil under the brand names of Modavigil